"Superpig: The Savior of the World's Bacon Crisis"
A U.K.-based company, Genus, has developed a gene-edited pig that is resistant to the devastating PRRS virus, potentially becoming the first genetically modified animal approved for wide human consumption by the FDA. The altered pig, created through a technique that disables a receptor necessary for the virus to establish infection, aims to address the $2.7 billion annual cost to the pork industry and improve animal welfare. While the approval process is complex, this development marks a shift in the GMO debate to include meat, though reducing pork consumption for environmental reasons remains a consideration.
